Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation.

Abstract

Gene replacement therapy is a rational therapeutic strategy and clinical intervention for neurodegenerative disorders like Canavan disease, a leukodystrophy caused by biallelic mutations in the aspartoacylase (ASPA) gene. We aimed to investigate whether simultaneous intravenous (i.v.) and intracerebroventricular (i.c.v.) administration of rAAV9-CB6-ASPA provides a safe and effective therapeutic strategy in an open-label, individual-patient, expanded-access trial for Canavan disease. Immunomodulation was given prophylactically prior to adeno-associated virus (AAV) treatment to prevent an immune response to ASPA or the vector capsid. The patient served as his own control, and change from baseline was assessed by clinical pathology tests, vector genomes in the blood, antibodies against ASPA and AAV capsids, levels of cerebrospinal fluid (CSF) N-acetylaspartate (NAA), brain water content and morphology, clinical status, and motor function tests. Two years post treatment, the patient's white matter myelination had increased, motor function was improved, and he remained free of typical severe epilepsy. NAA level was reduced at 3 months and remained stable up to 4 years post treatment. Immunomodulation prior to AAV exposure enables repeat dosing and has prevented an anti-transgene immune response. Dual-route administration of gene therapy may improve treatment outcomes.

• Authors: Manuela Corti, Barry J Byrne, Dominic J Gessler, Grace Thompson, Samantha Norman, Jenna Lammers, Kirsten E Coleman, Cristina Liberati, Melissa E Elder, Maria L Escolar, Ibrahim S Tuna, Clementina Mesaros, Gary I Kleiner, Deborah S Barbouth, Heather L Gray-Edwards, Nathalie Clement, Brian D Cleaver, Guangping Gao
• Journal: Molecular therapy. Methods & clinical development (Mol Ther Methods Clin Dev) Vol. 30 Pg. 303-314 (Sep 14 2023) ISSN: 2329-0501 [Print] United States
• PMID: 37601414 (Publication Type: Journal Article)
• Copyright: © 2023.